- Home
- KRYS vs BMA Comparison
KRYS vs BMA Comparison
Compare KRYS & BMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- BMA
- Stock Information
- Founded
- KRYS 2015
- BMA 1966
- Country
- KRYS United States
- BMA Argentina
- Employees
- KRYS N/A
- BMA N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- BMA Commercial Banks
- Sector
- KRYS Health Care
- BMA Finance
- Exchange
- KRYS Nasdaq
- BMA Nasdaq
- Market Cap
- KRYS 4.7B
- BMA 4.2B
- IPO Year
- KRYS 2017
- BMA 2006
- Fundamental
- Price
- KRYS $196.65
- BMA $85.82
- Analyst Decision
- KRYS Strong Buy
- BMA Strong Buy
- Analyst Count
- KRYS 9
- BMA 6
- Target Price
- KRYS $214.22
- BMA $81.70
- AVG Volume (30 Days)
- KRYS 316.5K
- BMA 911.5K
- Earning Date
- KRYS 11-03-2025
- BMA 11-26-2025
- Dividend Yield
- KRYS N/A
- BMA 1.64%
- EPS Growth
- KRYS 275.72
- BMA N/A
- EPS
- KRYS 6.66
- BMA 0.50
- Revenue
- KRYS $373,164,000.00
- BMA $2,573,406,817.00
- Revenue This Year
- KRYS $34.33
- BMA N/A
- Revenue Next Year
- KRYS $48.04
- BMA $3.01
- P/E Ratio
- KRYS $29.71
- BMA $17.37
- Revenue Growth
- KRYS 54.51
- BMA N/A
- 52 Week Low
- KRYS $122.80
- BMA $38.30
- 52 Week High
- KRYS $212.98
- BMA $118.42
- Technical
- Relative Strength Index (RSI)
- KRYS 59.19
- BMA 73.36
- Support Level
- KRYS $194.92
- BMA $86.34
- Resistance Level
- KRYS $212.98
- BMA $92.30
- Average True Range (ATR)
- KRYS 8.35
- BMA 5.47
- MACD
- KRYS -0.17
- BMA 1.63
- Stochastic Oscillator
- KRYS 42.14
- BMA 78.30
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About BMA Banco Macro S.A. ADR (representing Ten Class B)
Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.